Empiriko Corporation, a biotech company that has developed a novel in vitro biomimetic platform to accelerate small molecule drug development with current focus on antiviral therapies. The company is also developing a point-of-care diagnostic platform for personalized immunologic/genetic biomarker and drug monitoring. The synergies between these platforms enables Empiriko to cost effectively accelerate drug development and customize patient treatment for improved clinical outcomes.
View Top Employees from Empiriko CorporationWebsite | http://www.empiriko.com |
Revenue | $8 million |
Employees | 4 (4 on RocketReach) |
Founded | 2013 |
Address | 275 Grove St Suite 2-400, Newton, Massachusetts 02466, US |
Phone | (617) 340-3098 |
Technologies |
JavaScript,
HTML,
Twitter
+7 more
(view full list)
|
Industry | Biotechnology Research, Business Services General, Biotechnology, Business Services, Other Healthcare |
Competitors | AmberGen, Amethyst Technologies, LLC, Progenika, RETROGEN, INC., TetraGenetics Inc. |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 541714 Companies, NAICS Code 541 Companies, NAICS Code 5417 Companies |
Looking for a particular Empiriko Corporation employee's phone or email?
The Empiriko Corporation annual revenue was $8 million in 2024.
Rita Charnis is the Director, Bioanalysis of Empiriko Corporation.
4 people are employed at Empiriko Corporation.
Empiriko Corporation is based in Newton, Massachusetts.
The NAICS codes for Empiriko Corporation are [54171, 54, 541714, 541, 5417].
The SIC codes for Empiriko Corporation are [87, 873].